Valuation: Roche Holding AG

Market Cap 303B 367B 327B 275B 518B 34,865B 527B 3,643B 1,430B 18,173B 1,378B 1,349B 57,963B P/E 2026 *
20.5x
P/E 2027 * 18.6x
Enterprise Value 314B 380B 339B 285B 537B 36,118B 546B 3,774B 1,482B 18,826B 1,427B 1,397B 60,046B EV / Sales 2026 *
4.99x
EV / Sales 2027 * 4.67x
Free-Float
88.78%
Yield 2026 *
2.64%
Yield 2027 * 2.7%

Last Transcript: Roche Holding AG

1 day-0.41%
1 week+4.91%
Current month+6.60%
1 month+4.34%
3 months+13.25%
6 months+15.77%
Current year+14.74%
1 week 367.4
Extreme 367.4
387
1 month 353.8
Extreme 353.8
387
Current year 301.2
Extreme 301.2
387
1 year 270.8
Extreme 270.8
387
3 years 229.4
Extreme 229.4
387
5 years 229.4
Extreme 229.4
439.2
10 years 209.4
Extreme 209.4
439.2
Manager TitleAgeSince
Chief Executive Officer 51 15/03/2023
Director of Finance/CFO 59 06/06/2011
Chief Operating Officer - 01/10/2025
Director TitleAgeSince
Director/Board Member 68 01/01/1996
Chairman 59 15/03/2023
Director/Board Member 73 03/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%+4.91% - - 367B
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average -0.20%+3.61%+34.40%+61.25% 437.88B
Weighted average by Cap. +0.09%+3.83%+39.34%+71.82%

Financials

2026 *2027 *
Net sales 62.87B 76.22B 67.98B 57.2B 108B 7,241B 109B 757B 297B 3,774B 286B 280B 12,038B 65.79B 79.76B 71.14B 59.86B 113B 7,578B 115B 792B 311B 3,950B 299B 293B 12,598B
Net income 14.76B 17.89B 15.96B 13.43B 25.28B 1,700B 25.7B 178B 69.73B 886B 67.18B 65.75B 2,826B 16.37B 19.84B 17.7B 14.89B 28.03B 1,885B 28.5B 197B 77.34B 983B 74.51B 72.92B 3,134B
Net Debt 10.88B 13.19B 11.76B 9.89B 18.63B 1,253B 18.94B 131B 51.39B 653B 49.51B 48.45B 2,082B 4.26B 5.16B 4.6B 3.87B 7.29B 490B 7.41B 51.22B 20.11B 255B 19.37B 18.96B 815B
Projected Income Statement - Annual - Roche Holding AG
Logo Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Employees
103,249
Date Price Change Volume
16/10/26 CHF 384.60 -0.41% 25,130
15/10/26 CHF 386.20 +2.01% 75,032
14/10/26 CHF 378.60 +2.77% 21,331
13/10/26 CHF 368.40 -0.38% 15,977
12/10/26 CHF 369.80 +0.87% 14,752
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Roche Holding AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
379.20CHF
Average target price
377.24CHF
Spread / Average Target
-0.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Roche Holding AG